Malaysia vs Uruguay: HIV-positive TB patients on ART (antiretroviral therapy)
Malaysia
39.0%
in 2024
Uruguay
39.0%
in 2024
Malaysia rank
140th
Uruguay rank
140th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Malaysia
- Uruguay
How they compare
Malaysia currently reports 39.0% against 39.0% in Uruguay, a difference of 0.0%.
The two have swapped places 8 times across 18 shared years of data; in 2007 it was Uruguay ahead.
Malaysia ranks 140th and Uruguay ranks 140th of 144 countries.
Uruguay has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malaysia | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.1% | 21.0% | 1.9% | Uruguay |
| 2010s | 37.1% | 51.1% | 14.0% | Uruguay |
| 2020s | 33.2% | 37.6% | 4.4% | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Malaysia or Uruguay?
- Malaysia, at 39.0% against 39.0% in Uruguay as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Malaysia and Uruguay?
- 0.0%, with Malaysia ahead.
- How many years of comparable data are there for Malaysia and Uruguay?
- 18 years are reported by both, from 2007 to 2024.
- How do Malaysia and Uruguay rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Malaysia ranks 140th and Uruguay ranks 140th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.